About

In 2011 Kevin Abbott, Managing Director of Capa Valve, developed a piece of equipment to fill a domestic central heating system with rust inhibitor and mains water. The prototype system worked well, so Mr Abbott looked into patenting the device. His patent agent advised that, despite its simplicity, the valve was indeed novel and, if miniaturised, could be used in medical syringes to provide a dual-stage dispensing of two different liquids. Mr Abbott’s original patents, granted in Europe, UK and US, form the basis of this new pressure-activated valve configuration.

Contributions

DUAL CHAMBER

CAPA VALVE LAUNCHES NEW VALVE SYSTEM FOR DUAL-CHAMBER DEVICES

Dr Phil Green and Kevin Abbott discuss how Capa Valve’s patented valve technology provides a compelling alternative to bypass-based dual-chamber syringes, as its pressure-sensitive valve-based design enables much greater compatibility with existing fill-finish infrastructure and offers the flexibility to precisely tune the device via the geometric position of the valve within the syringe barrel.

More contributions

EARLY INSIGHT

CAPA VALVE’S PATENTED TECHNOLOGY TRANSFORMS ANY SYRINGE INTO A DCD

Phil Green, Dale Charlton and Kevin Abbott introduce Capa Valve’s novel valve system for converting standard syringes into prefilled dual-chamber devices, capable of simplifying and improving the delivery of liquid-liquid and liquid-powder drug products, including reconstitution of lyophilised powders.